Page last updated: 2024-08-17

medroxyprogesterone acetate and Adenohypophyseal Hyposecretion

medroxyprogesterone acetate has been researched along with Adenohypophyseal Hyposecretion in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Akay, HO; Bahceci, M; Gokalp, D; Pasa, S; Tumer, C; Tuzcu, A	1

Trials

1 trial(s) available for medroxyprogesterone acetate and Adenohypophyseal Hyposecretion

Article	Year
Serum nitric oxide levels and flow-mediated dilatation in patients with Sheehan syndrome and the effect of combination therapy consisting of L-thyroxine, prednisolone, and conjugated estrogen/medroxyprogesterone acetate. Fertility and sterility, 2008, Volume: 89, Issue:4 Topics: Adult; Brachial Artery; Drug Therapy, Combination; Estrogens, Conjugated (USP); Female; Humans; Hyperemia; Hypopituitarism; Medroxyprogesterone Acetate; Middle Aged; Nitric Oxide; Prednisolone; Thyroxine; Treatment Outcome; Ultrasonography; Vasodilation	2008

Article

Year

Serum nitric oxide levels and flow-mediated dilatation in patients with Sheehan syndrome and the effect of combination therapy consisting of L-thyroxine, prednisolone, and conjugated estrogen/medroxyprogesterone acetate.

Fertility and sterility, 2008, Volume: 89, Issue:4

Topics: Adult; Brachial Artery; Drug Therapy, Combination; Estrogens, Conjugated (USP); Female; Humans; Hyperemia; Hypopituitarism; Medroxyprogesterone Acetate; Middle Aged; Nitric Oxide; Prednisolone; Thyroxine; Treatment Outcome; Ultrasonography; Vasodilation

2008